A European pharmaceutical company initiative challenging the regulatory requirement for acute toxicity studies in pharmaceutical drug development
2007104 citationsJournal Article
Field-Weighted Citation Impact: 8.21
A European pharmaceutical company initiative challenging the regulatory requirement for acute toxicity studies in pharmaceutical drug development | Researchclopedia